247 related articles for article (PubMed ID: 29658344)
1. Effect of 12-month treatment with metformin and/or oral contraceptives on health-related quality of life in polycystic ovary syndrome.
Altinok ML; Ravn P; Andersen M; Glintborg D
Gynecol Endocrinol; 2018 Oct; 34(10):859-863. PubMed ID: 29658344
[TBL] [Abstract][Full Text] [Related]
2. Metformin versus the combined oral contraceptive pill for hirsutism, acne, and menstrual pattern in polycystic ovary syndrome.
Fraison E; Kostova E; Moran LJ; Bilal S; Ee CC; Venetis C; Costello MF
Cochrane Database Syst Rev; 2020 Aug; 8(8):CD005552. PubMed ID: 32794179
[TBL] [Abstract][Full Text] [Related]
3. Differential Effects on Haemostatic Markers by Metformin and the Contraceptive Pill: A Randomized Comparative Trial in PCOS.
Burchall GF; Piva TJ; Ranasinha S; Teede HJ
Thromb Haemost; 2017 Nov; 117(11):2053-2062. PubMed ID: 29202210
[No Abstract] [Full Text] [Related]
4. Body composition is improved during 12 months' treatment with metformin alone or combined with oral contraceptives compared with treatment with oral contraceptives in polycystic ovary syndrome.
Glintborg D; Altinok ML; Mumm H; Hermann AP; Ravn P; Andersen M
J Clin Endocrinol Metab; 2014 Jul; 99(7):2584-91. PubMed ID: 24742124
[TBL] [Abstract][Full Text] [Related]
5. Adiponectin, interleukin-6, monocyte chemoattractant protein-1, and regional fat mass during 12-month randomized treatment with metformin and/or oral contraceptives in polycystic ovary syndrome.
Glintborg D; Mumm H; Altinok ML; Richelsen B; Bruun JM; Andersen M
J Endocrinol Invest; 2014 Aug; 37(8):757-764. PubMed ID: 24906976
[TBL] [Abstract][Full Text] [Related]
6. Endothelial function and insulin resistance in polycystic ovary syndrome: the effects of medical therapy.
Teede HJ; Meyer C; Hutchison SK; Zoungas S; McGrath BP; Moran LJ
Fertil Steril; 2010 Jan; 93(1):184-91. PubMed ID: 19019358
[TBL] [Abstract][Full Text] [Related]
7. Metformin improved health-related quality of life in ethnic Chinese women with polycystic ovary syndrome.
Ou HT; Chen PC; Wu MH; Lin CY
Health Qual Life Outcomes; 2016 Aug; 14(1):119. PubMed ID: 27553217
[TBL] [Abstract][Full Text] [Related]
8. Metformin improves endothelial function and carotid intima media thickness in patients with PCOS.
Kaya MG; Yildirim S; Calapkorur B; Akpek M; Unluhizarci K; Kelestimur F
Gynecol Endocrinol; 2015 May; 31(5):401-5. PubMed ID: 25791462
[TBL] [Abstract][Full Text] [Related]
9. Randomized controlled trial evaluating response to metformin versus standard therapy in the treatment of adolescents with polycystic ovary syndrome.
Allen HF; Mazzoni C; Heptulla RA; Murray MA; Miller N; Koenigs L; Reiter EO
J Pediatr Endocrinol Metab; 2005 Aug; 18(8):761-8. PubMed ID: 16200842
[TBL] [Abstract][Full Text] [Related]
10. Randomized clinical trial evaluating metformin versus oral contraceptive pills in the treatment of adolescents with polycystic ovarian syndrome.
Al-Zubeidi H; Klein KO
J Pediatr Endocrinol Metab; 2015 Jul; 28(7-8):853-8. PubMed ID: 25781525
[TBL] [Abstract][Full Text] [Related]
11. Oral contraceptives increase platelet microparticle levels in normal-weight women with polycystic ovary syndrome.
Papadakis E; Sarigianni M; Tziomalos K; Mavromatidis G; Panidis D
Hormones (Athens); 2020 Dec; 19(4):565-571. PubMed ID: 32078734
[TBL] [Abstract][Full Text] [Related]
12. The effects of treatment with drospirenone/ethinyl oestradiol alone or in combination with metformin on elastic properties of aorta in women with polycystic ovary syndrome.
Kaya MG; Calapkorur B; Karaca Z; Yildirim S; Celik A; Akpek M; Unluhizarci K; Kelestimur F
Clin Endocrinol (Oxf); 2012 Dec; 77(6):885-92. PubMed ID: 22563947
[TBL] [Abstract][Full Text] [Related]
13. Impact of metformin, oral contraceptives, and lifestyle modification on polycystic ovary syndrome in obese adolescent women: do we need a new drug?
Legro RS
J Clin Endocrinol Metab; 2008 Nov; 93(11):4218-20. PubMed ID: 18987279
[No Abstract] [Full Text] [Related]
14. Weight Loss and Lowering Androgens Predict Improvements in Health-Related Quality of Life in Women With PCOS.
Dokras A; Sarwer DB; Allison KC; Milman L; Kris-Etherton PM; Kunselman AR; Stetter CM; Williams NI; Gnatuk CL; Estes SJ; Fleming J; Coutifaris C; Legro RS
J Clin Endocrinol Metab; 2016 Aug; 101(8):2966-74. PubMed ID: 27253669
[TBL] [Abstract][Full Text] [Related]
15. The benefit-to-risk ratio of common treatments in PCOS: effect of oral contraceptives versus metformin on atherogenic markers.
Christakou C; Kollias A; Piperi C; Katsikis I; Panidis D; Diamanti-Kandarakis E
Hormones (Athens); 2014; 13(4):488-97. PubMed ID: 25555182
[TBL] [Abstract][Full Text] [Related]
16. Novel inflammatory markers in overweight women with and without polycystic ovary syndrome and following pharmacological intervention.
Moran LJ; Meyer C; Hutchison SK; Zoungas S; Teede HJ
J Endocrinol Invest; 2010 Apr; 33(4):258-65. PubMed ID: 19834313
[TBL] [Abstract][Full Text] [Related]
17. Metformin or Oral Contraceptives for Adolescents With Polycystic Ovarian Syndrome: A Meta-analysis.
Al Khalifah RA; Florez ID; Dennis B; Thabane L; Bassilious E
Pediatrics; 2016 May; 137(5):. PubMed ID: 27244814
[TBL] [Abstract][Full Text] [Related]
18. Improved efficacy of low-dose spironolactone and metformin combination than either drug alone in the management of women with polycystic ovary syndrome (PCOS): a six-month, open-label randomized study.
Ganie MA; Khurana ML; Nisar S; Shah PA; Shah ZA; Kulshrestha B; Gupta N; Zargar MA; Wani TA; Mudasir S; Mir FA; Taing S
J Clin Endocrinol Metab; 2013 Sep; 98(9):3599-607. PubMed ID: 23846820
[TBL] [Abstract][Full Text] [Related]
19. Changes in weight, papilledema, headache, visual field, and life status in response to diet and metformin in women with idiopathic intracranial hypertension with and without concurrent polycystic ovary syndrome or hyperinsulinemia.
Glueck CJ; Golnik KC; Aregawi D; Goldenberg N; Sieve L; Wang P
Transl Res; 2006 Nov; 148(5):215-22. PubMed ID: 17145568
[TBL] [Abstract][Full Text] [Related]
20. The Pharmacogenetics of Metformin in Women with Polycystic Ovary Syndrome: A Randomized Trial.
Pedersen AJT; Stage TB; Glintborg D; Andersen M; Christensen MMH
Basic Clin Pharmacol Toxicol; 2018 Feb; 122(2):239-244. PubMed ID: 28834135
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
